360 filings
Page 4 of 18
S-8
mpl9 jklfcr
11 Mar 22
Registration of securities for employees
4:21pm
8-K
xqq8cyn
10 Mar 22
Viridian Therapeutics Reports Fourth Quarter and Full Year 2021
4:16pm
EFFECT
5e7y2kp
18 Nov 21
Notice of effectiveness
12:15am
CORRESP
fhhh9 pcnhc581thd
15 Nov 21
Correspondence with SEC
12:00am
UPLOAD
ig3l6qwkk4pow
10 Nov 21
Letter from SEC
12:00am
8-K
a8x tkqul9t2evdzboo
8 Nov 21
Other Events
9:08am
8-K
bd5q228 a00r476
4 Nov 21
Viridian Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
4:17pm
8-K
ojk3 ags90r
23 Sep 21
Entry into a Material Definitive Agreement
4:30pm
424B5
w4m3yo3ciz gs4cru9u
22 Sep 21
Prospectus supplement for primary offering
5:20pm
424B5
q9z6xmek1z3zryj d7
20 Sep 21
Prospectus supplement for primary offering
4:12pm
8-K
wnu4ly6e
11 Aug 21
Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
7:17am
8-K
d5pbh
26 Jul 21
Viridian Therapeutics Appoints Kristian Humer As Chief
7:35am
8-K
ns2imy
15 Jul 21
Viridian Therapeutics Appoints Jennifer Moses, Cpa to the Board of Directors and As Chair of the Audit Committee
4:13pm
8-K/A
0qlspxq13hddjghl4yo
15 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:30pm
DEFA14A
xe7r9a8
4 Jun 21
Additional proxy soliciting materials
6:13am
8-K
5pw4sdq9k4 uwxv
4 Jun 21
Departure of Directors or Certain Officers
6:08am